Press Releases

March 24, 2021

CyanVac selects Exothera for the development and GMP manufacturing of its COVID-19 intranasal vaccine candidate for phase III clinical trial in Europe and the US

Read the press release

January 28, 2021

Exothera completes its range of state-of-the-art technologies by acquiring the new generation of the NevoLine™ Upstream platform for its new site in Belgium

Read the press release

March 19, 2020

Univercells launches cell & gene therapy contract development and manufacturing organization (CDMO) Exothera with GMP capabilities in 15,000m² site in Jumet, Belgium

Read the press release